CBD Reduced Gut Symptoms of Opioid Withdrawal in Mice | Research

The takeaway

CBD dose-dependently reduced gastrointestinal symptoms of opioid withdrawal in both male and female mice, suggesting a potential therapeutic target for managing withdrawal discomfort.

Researchers studying opioid withdrawal treatments and CBD therapeutics

CBD reduced GI withdrawal symptoms at all three doses tested

What the researchers found

CBD at 10, 30, and 100 mg/kg dose-dependently reduced gastrointestinal symptoms (diarrhea, fecal output, weight loss) during both precipitated and spontaneous oxycodone withdrawal in male mice and during precipitated withdrawal in female mice. Effects on other withdrawal symptoms (jumping, paw tremors) were less consistent.

Why it matters

Opioid withdrawal is a major driver of continued drug use, and current treatments have limitations. The gastrointestinal symptoms (nausea, diarrhea, cramping) are among the most distressing. Finding that CBD specifically targets these symptoms opens a potential complementary treatment avenue.

The numbers in context

CBD tested at 10, 30, and 100 mg/kg. Oxycodone escalated from 9 to 33 mg/kg over 8 days. Male mice showed withdrawal effects in both precipitated and spontaneous conditions; female mice only showed precipitated withdrawal effects. GI symptom reduction was consistent across both sexes in precipitated withdrawal.

How the study worked

Mice received escalating oxycodone doses over 8 days, then underwent either naloxone-precipitated or spontaneous withdrawal. CBD was administered 60 minutes before testing at 0, 10, 30, or 100 mg/kg. Gastrointestinal symptoms, somatic symptoms, and negative affect behaviors were measured.

What this study cannot tell us

Animal study results may not translate to humans. Doses used were relatively high. Female mice showed less robust withdrawal syndrome overall, making it harder to evaluate CBD's effects in that group. The study did not examine long-term outcomes or relapse.

How to read the evidence

Well-designed animal study with dose-response data and sex comparisons, but preclinical findings require human validation.

When this study was published

2024 study (published 2022 online, journal 2024)

The bigger picture

The opioid crisis has driven interest in non-opioid approaches to managing withdrawal. CBD, which is already available clinically and has a favorable safety profile, could potentially be integrated into withdrawal management protocols if these findings translate to humans.

Questions still open

Why did female mice show a less pronounced withdrawal syndrome? Would CBD be effective at clinically relevant doses in humans? Could CBD be combined with existing withdrawal medications for additive benefit?

Common questions

Can CBD help with opioid withdrawal?

In mice, CBD reduced the gastrointestinal symptoms of opioid withdrawal (diarrhea, weight loss) in a dose-dependent manner. Human studies are still needed.

Which opioid withdrawal symptoms did CBD affect?

CBD was most effective against gastrointestinal symptoms. It had less consistent effects on other withdrawal behaviors like jumping and paw tremors.

Read the original research

Cannabidiol Reduced the Severity of Gastrointestinal Symptoms of Opioid Withdrawal in Male and Female Mice.

Cannabis and cannabinoid research, 9(2), 547-560

View on PubMed ↗Publisher’s paper ↗

Citation

Scicluna, Rhianne L; Wilson, Bianca B; Thelaus, Samuel H; Arnold, Jonathon C; McGregor, Iain S; Bowen, Michael T. (2024). Cannabidiol Reduced the Severity of Gastrointestinal Symptoms of Opioid Withdrawal in Male and Female Mice.. Cannabis and cannabinoid research, 9(2), 547-560. https://doi.org/10.1089/can.2022.0036